Antimicrobial Agents Practice Questions

Q: What is the role of ethambutol in the Revised National Tuberculosis Control Programme (RNTCP) regimen?

Bacteriostatic and detrimental to fast multiplying bacilli. ### Explanation **1. Why the Correct Answer is Right:** Ethambutol is a **bacteriostatic** antitubercular drug. Its primary mechanism of action involves the inhibition of the enzyme **arabinosyl transferase**, which is essential for the synthesis of arabinogalactan (a critical component of the mycobacterial cell wall). Since cell wall synthesis occurs most actively during cell division, ethambutol is most effective against **fast-multiplying bacilli** (extracellular bacteria). By inhibiting wall synthesis, it prevents the multiplication of the bacteria rather than killing them directly. **2. Why the Other Options are Wrong:** * **Options A & B (Bactericidal):** Ethambutol is the only primary antitubercular drug that is bacteriostatic at standard therapeutic doses. Drugs like Isoniazid, Rifampicin, and Pyrazinamide are bactericidal. * **Options B & D (Dormant/Slow multiplying):** Ethambutol has no significant activity against dormant (latent) or slow-multiplying (intracellular) bacilli. **Pyrazinamide** is the drug of choice for acidic environments (intracellular/slow-multiplying), while **Rifampicin** is highly effective against spurters (semidormant bacilli). **3. NEET-PG High-Yield Clinical Pearls:** * **Visual Side Effects:** The most characteristic side effect is **Retrobulbar Neuritis**, leading to decreased visual acuity, central scotoma, and **red-green color blindness**. It is generally dose-dependent and reversible. * **Contraindication:** It should be avoided in children below 6 years of age because they cannot reliably report changes in visual acuity or color perception. * **Uric Acid:** Like Pyrazinamide, Ethambutol can decrease the excretion of uric acid, potentially leading to **hyperuricemia**. * **Role in RNTCP:** Its primary role in the Intensive Phase (2HRZE) is to prevent the emergence of resistance to more potent drugs like Isoniazid and Rifampicin.

Q: A person on anti-tubercular drugs complained of deafness and tinnitus in one ear. Which drug is most likely implicated?

Streptomycin. **Explanation:** The correct answer is **Streptomycin**. **1. Why Streptomycin is correct:** Streptomycin is an **Aminoglycoside** antibiotic used as a first-line injectable drug in the treatment of Tuberculosis. The hallmark toxicity of aminoglycosides is **ototoxicity**, which occurs due to the destruction of sensory hair cells in the inner ear. Streptomycin specifically targets the **vestibulocochlear nerve (Cranial Nerve VIII)**. While it is more vestibulotoxic (causing vertigo and ataxia), it also causes permanent cochlear damage, leading to **tinnitus and sensorineural hearing loss (deafness)**. **2. Why the other options are incorrect:** * **Isoniazid (INH):** The most characteristic side effect is **peripheral neuropathy** (due to Vitamin B6 deficiency) and hepatotoxicity. It does not affect hearing. * **Ethambutol:** The classic adverse effect is **retrobulbar neuritis**, which manifests as decreased visual acuity and **red-green color blindness**. It is not ototoxic. * **Rifampicin:** Known for causing **orange-colored discoloration** of body fluids (urine, sweat, tears) and hepatotoxicity. It does not cause deafness. **Clinical Pearls for NEET-PG:** * **Ototoxicity:** Streptomycin is more vestibulotoxic, whereas Amikacin and Kanamycin are more cochleotoxic. * **Pregnancy:** Streptomycin is **contraindicated in pregnancy** because it can cross the placenta and cause congenital deafness in the fetus. * **Renal Monitoring:** Since aminoglycosides are excreted unchanged by the kidneys, dose adjustment is required in renal failure to prevent both ototoxicity and nephrotoxicity. * **Mnemonic for Ethambutol:** **E**thambutol for **E**ye (Optic neuritis).

Q: A female patient treated with antibiotics for chlamydia-induced UTI presents with itching/pruritus, vaginal discharge, and burning micturition. Which drug should be given?

Azithromycin. ### **Explanation** **Correct Option: B. Azithromycin** The clinical scenario describes a patient with a **Chlamydial urinary tract infection (UTI)/Urethritis**. *Chlamydia trachomatis* is an obligate intracellular pathogen. **Azithromycin**, a macrolide, is the drug of choice because it achieves high intracellular concentrations and has a long half-life, allowing for a **single-dose (1g)** curative regimen. This ensures high patient compliance compared to multi-day courses. **Analysis of Incorrect Options:** * **A. Ceftriaxone:** This is a third-generation cephalosporin used primarily for *Neisseria gonorrhoeae*. While Chlamydia and Gonorrhea often co-infect, Ceftriaxone is ineffective against Chlamydia because the organism lacks a typical peptidoglycan cell wall (the target of beta-lactams). * **C. Moxifloxacin:** While some fluoroquinolones (like Ofloxacin or Levofloxacin) can treat Chlamydia, they are second-line agents. Moxifloxacin is generally reserved for respiratory infections or resistant Pelvic Inflammatory Disease (PID) and is not the primary choice for uncomplicated Chlamydial UTI. * **D. Amphotericin B:** This is a potent antifungal used for systemic fungal infections (e.g., Mucormycosis). It has no activity against bacterial pathogens like Chlamydia. **NEET-PG High-Yield Pearls:** * **DOC for Chlamydia:** Azithromycin (1g stat) or Doxycycline (100mg BID for 7 days). * **Pregnancy:** Azithromycin is the preferred agent for Chlamydia in pregnant women (Doxycycline is contraindicated due to fetal bone/teeth effects). * **Syndromic Management (Green Kit):** Used for vaginal discharge; contains Fluconazole (for Candidiasis) and Azithromycin (for Chlamydia). * **Reiter’s Syndrome:** A classic triad of "Can't see, can't pee, can't climb a tree" (Uveitis, Urethritis, Arthritis) often triggered by a Chlamydia infection.

Q: Which of the following is a fifth-generation cephalosporin?

Ceftaroline. **Explanation:** **Ceftaroline** is the correct answer as it is a member of the **fifth-generation cephalosporins**. The defining clinical characteristic of this generation is its unique ability to bind to **PBP-2a**, an altered penicillin-binding protein that confers resistance in Staphylococci. This makes fifth-generation agents the only cephalosporins effective against **Methicillin-resistant *Staphylococcus aureus* (MRSA)**. **Analysis of Incorrect Options:** * **Cefepime (Option A):** This is a **fourth-generation** cephalosporin. It is a "zwitterion" that can rapidly penetrate the outer membrane of Gram-negative bacteria. It is highly effective against *Pseudomonas aeruginosa* but lacks activity against MRSA. * **Cefpirome (Option C):** Also a **fourth-generation** cephalosporin, similar in spectrum to Cefepime, primarily used for life-threatening nosocomial infections. * **Cefprozil (Option D):** This is a **second-generation** oral cephalosporin used mainly for respiratory tract infections and skin/soft tissue infections. **High-Yield Clinical Pearls for NEET-PG:** * **Fifth-Generation Agents:** Include **Ceftaroline** and **Ceftobiprole**. * **MRSA Coverage:** Remember the mnemonic: "Ceftaroline covers the 'Staph' that others can't." * **VRSA & VISA:** Ceftaroline also shows activity against Vancomycin-resistant and Vancomycin-intermediate *S. aureus*. * **LAME Mnemonic:** Cephalosporins generally do **NOT** cover **L**isteria, **A**typicals (Mycoplasma/Chlamydia), **M**RSA (except 5th gen), and **E**nterococci (except Ceftaroline/Ceftobiprole which have some Enterococcal activity). * **Excretion:** Most cephalosporins are renally excreted; **Ceftriaxone** is a notable exception (biliary excretion), requiring no dose adjustment in renal failure.

Q: What is the mechanism of action of Oseltamivir and Zanamivir?

Neuraminidase inhibition. **Mechanism of Action: Neuraminidase Inhibitors** **Correct Answer: D. Neuraminidase inhibition** Oseltamivir and Zanamivir are structural analogs of sialic acid. Their primary mechanism involves the competitive inhibition of **Neuraminidase (NA)**, an enzyme found on the surface of Influenza A and B viruses. * **The Concept:** During the viral life cycle, new virions bud from the host cell membrane but remain attached via hemagglutinin to sialic acid receptors. Neuraminidase cleaves these receptors, allowing the release of progeny virions. By inhibiting this enzyme, Oseltamivir and Zanamivir cause the newly formed viruses to clump together and remain stuck to the host cell, thereby preventing the infection of new cells. **Why other options are incorrect:** * **A & B (DNA polymerase/mRNA inhibition):** These are mechanisms typical of anti-herpetic drugs (e.g., Acyclovir) or certain RNA polymerase inhibitors (e.g., Ribavirin). Influenza is an RNA virus, and these drugs do not target its genetic replication directly. * **C (Blocking viral uncoating):** This is the mechanism of **Amantadine and Rimantadine**, which inhibit the **M2 ion channel** [3]. These drugs are now largely obsolete due to widespread resistance. **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** These drugs are most effective when started within **48 hours** of symptom onset [1], [2]. * **Routes:** Oseltamivir is **oral** (prodrug) [2], while Zanamivir is **inhaled** (contraindicated in asthma/COPD due to risk of bronchospasm). * **Peramivir:** An intravenous neuraminidase inhibitor used for acute uncomplicated influenza. * **Baloxavir Marboxil:** A newer agent that inhibits **cap-dependent endonuclease**, blocking viral mRNA synthesis (a frequent "next-step" question).

Q: Tetracycline stains appear as:

Yellow and brown stains in enamel and dentin. **Explanation:** Tetracyclines are known for their high affinity for calcium. When administered during the period of tooth development (calcification), they form a stable **tetracycline-calcium orthophosphate complex**. This complex is deposited in both the **enamel and the dentin** of developing teeth. **Why Option A is correct:** The staining occurs because tetracyclines are incorporated into the hydroxyapatite crystals of both the enamel and the dentin. Initially, the stain appears as a bright yellow fluorescence under UV light. Over time, due to photo-oxidation upon exposure to light, the color transitions to a permanent brownish-gray or yellow-brown discoloration. **Why other options are incorrect:** * **Options B & C:** These are incorrect because the drug does not selectively target one layer; it is deposited in all calcifying tissues, including the enamel, dentin, and even the cementum. * **Option D:** This is incorrect because the color is not limited to yellow; the characteristic clinical presentation is a progression from yellow to brown/gray. **NEET-PG High-Yield Pearls:** * **Critical Period:** Tetracyclines should be avoided from the **14th week of gestation to 8 years of age**. * **Deciduous vs. Permanent:** Exposure in utero affects deciduous (baby) teeth; exposure after birth affects permanent dentition [1]. * **Bone Growth:** Tetracyclines can also deposit in growing bones, leading to a temporary depression of linear bone growth. * **Minocycline Exception:** Unlike other tetracyclines, Minocycline can cause staining in **adult teeth** (post-eruptive) due to its presence in gingival crevicular fluid or systemic distribution. * **Contraindication:** Tetracyclines are **Category D** drugs in pregnancy.

Q: Which of the following drugs has cochlear involvement more than vestibular involvement?

Kanamycin. Aminoglycosides are notorious for their **ototoxicity**, which occurs due to the accumulation of the drug in the perilymph and endolymph, leading to the destruction of sensory hair cells. Degeneration of hair cells and neurons in the cochlea correlates with the loss of hearing [1]. This toxicity is broadly categorized into **vestibular** (balance) and **cochlear** (hearing) involvement. **1. Why Kanamycin is Correct:** Aminoglycosides exhibit a preference for specific parts of the inner ear. **Kanamycin**, along with Amikacin and Neomycin, is primarily **cochleotoxic**. It causes the destruction of the outer hair cells in the Organ of Corti, leading to permanent high-frequency hearing loss. **2. Analysis of Incorrect Options:** * **Streptomycin:** Primarily **vestibulotoxic**. Its unwanted effects are ototoxicity (mainly vestibular) [3]. It targets the sensory cells of the cristae ampullaris, leading to vertigo, ataxia, and loss of balance. * **Gentamycin:** Primarily **vestibulotoxic**. Ototoxicity from gentamicin manifests itself mainly as vestibular dysfunction [2]. Like streptomycin, it affects balance more frequently than hearing. * **Sisomycin:** Primarily **vestibulotoxic**. It is a derivative of Gentamycin and shares a similar toxicity profile. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Mnemonic for Cochleotoxicity:** "**A**ll **N**ew **K**ids" (**A**mikacin, **N**eomycin, **K**anamycin). * **Mnemonic for Vestibulotoxicity:** "**S**ome **G**uys" (**S**treptomycin, **G**entamycin). * **Tobramycin** is unique as it affects both vestibular and cochlear functions almost equally. * **Risk Factors:** Ototoxicity is potentiated by the concurrent use of **Loop Diuretics** (e.g., Furosemide, Ethacrynic acid). * **Monitoring:** Since aminoglycosides are excreted renally, toxicity is higher in patients with renal impairment. Monitoring peak and trough levels is essential.

Q: Which of the following drugs is used to prevent HIV transmission from an HIV-positive pregnant mother to her child?

Nevirapine. **Explanation:** The prevention of mother-to-child transmission (PMTCT) of HIV is a critical clinical priority. **Nevirapine**, a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), is the drug of choice in this context due to its unique pharmacokinetic profile. **Why Nevirapine is correct:** Nevirapine has excellent bioavailability and a long half-life. Most importantly, it rapidly crosses the placenta and is secreted in breast milk. In the classic "WHO Option A" protocol (and historical single-dose regimens), a single dose given to the mother at the onset of labor and a single dose to the newborn within 72 hours significantly reduces the risk of vertical transmission. While modern guidelines (Option B+) now favor lifelong Triple Antiretroviral Therapy (ART) for the mother (usually containing Tenofovir, Lamivudine, and Dolutegravir), Nevirapine remains the classic exam answer for PMTCT prophylaxis. **Why other options are incorrect:** * **Lamivudine (3TC), Stavudine (d4T), and Didanosine (ddI):** These are Nucleoside Reverse Transcriptase Inhibitors (NRTIs). While they are used as part of combination ART regimens during pregnancy to reduce viral load, they are not used as monotherapy for the specific prevention of transmission during labor. Stavudine and Didanosine are now rarely used due to high mitochondrial toxicity (lactic acidosis and peripheral neuropathy). **High-Yield Clinical Pearls for NEET-PG:** * **Zidovudine (AZT):** Historically the first drug used for PMTCT (PCTG 076 protocol). It is still used as infant prophylaxis for 6 weeks post-delivery. * **Drug of Choice (Current):** For a pregnant woman, the preferred regimen is **TDF + 3TC + DTG** (Tenofovir + Lamivudine + Dolutegravir). * **Nevirapine Side Effect:** Watch for Stevens-Johnson Syndrome (SJS) and hepatotoxicity. * **Post-Exposure Prophylaxis (PEP):** Should be started within 2 hours (ideally) and no later than 72 hours, continuing for 28 days.

Question 1

What is the role of ethambutol in the Revised National Tuberculosis Control Programme (RNTCP) regimen?

Accepted Answer

Bacteriostatic and detrimental to fast multiplying bacilli

Answer

Bactericidal and detrimental to semidormant bacilli

Answer

Bactericidal and detrimental to dormant bacilli

Answer

Bacteriostatic and detrimental to slow multiplying bacilli

Question 2

A person on anti-tubercular drugs complained of deafness and tinnitus in one ear. Which drug is most likely implicated?

Accepted Answer

Streptomycin

Answer

Isoniazid

Answer

Ethambutol

Answer

Rifampicin

Question 3

Efavirenz limits HIV infection by:

Accepted Answer

Serving as an allosteric inhibitor of HIV reverse transcriptase

Answer

Binding to the active site of HIV reverse transcriptase

Answer

Impairing the binding of HIV virion to CD4 receptors on T-cells

Answer

Inhibiting the HIV protease

Question 4

A female patient treated with antibiotics for chlamydia-induced UTI presents with itching/pruritus, vaginal discharge, and burning micturition. Which drug should be given?

Accepted Answer

Azithromycin

Answer

Ceftriaxone

Answer

Moxifloxacin

Answer

Amphotericin B

Question 5

Which of the following is a fifth-generation cephalosporin?

Accepted Answer

Ceftaroline

Answer

Cefepime

Answer

Cefpirome

Answer

Cefprozil

Question 6

What is the mechanism of action of Oseltamivir and Zanamivir?

Accepted Answer

Neuraminidase inhibition

Answer

DNA polymerase inhibition

Answer

Inhibition of viral mRNA

Answer

Blocking viral uncoating

Question 7

Tetracycline stains appear as:

Accepted Answer

Yellow and brown stains in enamel and dentin

Answer

Yellow and brown stains only in enamel

Answer

Yellow and brown stains only in dentin

Answer

Only yellow stain in enamel

Question 8

Which of the following drugs has cochlear involvement more than vestibular involvement?

Accepted Answer

Kanamycin

Answer

Sisomycin

Answer

Gentamycin

Answer

Streptomycin

Question 9

Which antibiotic is recommended for the treatment of Toxic Shock Syndrome?

Accepted Answer

Clindamycin

Answer

Linezolid

Answer

Cephalexin

Answer

Quinupristin and dalfopristin

Question 10

Which of the following drugs is used to prevent HIV transmission from an HIV-positive pregnant mother to her child?

Accepted Answer

Nevirapine

Answer

Lamivudine

Answer

Stavudine

Answer

Didanosine

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?